Single dose safety study of adagrasib in healthy Japanese adults
Treatments studied
This trial tests a single dose of the drug adagrasib in healthy adults of Japanese descent. The goal is to see how the body processes the drug and if it is safe. This study does not involve treating a disease; it helps doctors understand the drug better for future research.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are of Japanese descent (both biological parents must be ethnically Japanese).
- You are a healthy adult with no major medical problems.
- Your body mass index (BMI) is between 18.0 and 32.0.
- You weigh at least 50 kg (about 110 pounds).
- You do not have a history of significant medical conditions like heart, lung, kidney, or liver disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine called AZD3974 in healthy people to see if it is safe and how the body handles it. It may help find the right dose for future studies.
This study tests a new drug called AZD4916 in healthy people to see if it's safe and how the body processes it. It may help decide if the drug is safe enough for future studies.
This trial tests a new drug called AZD4954 for safety. It includes healthy volunteers and people with high Lp(a) or dyslipidemia. The goal is to see if the drug is safe and how the body processes it.
This trial tests a single dose of an investigational drug called AMG 691 in healthy Chinese and Japanese volunteers to see how it is processed by the body and how safe it is. This is an early-phase study, so it may help make future treatments safer for people of similar backgrounds.
This is an early-stage safety study of an experimental medicine called JADE101. Researchers want to give a single dose to healthy volunteers of Japanese or Chinese heritage to see how the body handles it and watch for any side effects.
This is a first-in-human trial testing an experimental drug (AZD1613) in healthy volunteers. It helps doctors see if the drug is safe, how it is processed by the body, and how the immune system reacts. The trial is designed for healthy men and women who cannot become pregnant and may require participants to be of Chinese or Japanese descent for certain groups.
Hear when a new Healthy Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.